Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PavSnRK2.2, a member of the SNF1-related protein kinase 2 family, positively regulates ABA-induced fruit ripening in sweet cherry.

Plant physiology and biochemistry : PPB·2026
Same author

Isolation of Infectious Highly Pathogenic Avian Influenza A(H5N1) Virus from Fetal Bovine Serum, United States, 2025.

Emerging infectious diseases·2026
Same author

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same author

Salvia miltiorrhiza Bunge alleviates pulmonary fibrosis by promoting fibroblast mitophagy.

Journal of ethnopharmacology·2026
Same author

The transcription factor PavERF28 promotes fruit softening by regulating cell wall degradation in sweet cherry (Prunus avium L.).

International journal of biological macromolecules·2026
Same author

Linear and nonlinear modeling of selenium biomarker dynamics in Keshan disease: Insights for precision prevention from rats and human populations.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: May 21, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms.

Chen Feng1, Veronique Neumeister, Wei Ma

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA.

Cell Cycle (Georgetown, Tex.)
|June 21, 2012
PubMed
Summary

The RNA binding protein Lin28 stimulates the expression of HER2, a key protein in breast cancer. Lin28 overexpression predicts poor prognosis in breast cancer patients, highlighting its role in cancer progression.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Experiment Videos

Last Updated: May 21, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Lin28 and Lin28B are RNA binding proteins linked to advanced cancers.
  • They are known to inhibit the tumor suppressor let-7 miRNA, contributing to cancer.
  • HER2 is a critical receptor tyrosine kinase in breast cancer cell proliferation and survival.

Purpose of the Study:

  • To investigate the role of Lin28 in regulating HER2 expression.
  • To explore the mechanisms by which Lin28 promotes cancer cell growth.
  • To determine the clinical significance of Lin28 expression in breast cancer prognosis.

Main Methods:

  • Posttranscriptional regulation analysis of HER2 mRNA.
  • Enforced expression studies in cancer cells.
  • Correlation analysis of Lin28 expression with clinical outcomes in primary breast tumors.

Main Results:

  • Lin28 was identified as a regulator of HER2 mRNA.
  • Lin28 stimulates HER2 expression at the posttranscriptional level.
  • Enforced Lin28 expression promoted cancer cell growth through multiple pathways.
  • Lin28 overexpression is a strong predictor of poor prognosis in breast cancer.

Conclusions:

  • Lin28 regulates HER2 expression posttranscriptionally, adding to known gene amplification mechanisms.
  • Lin28 overexpression is linked to poor clinical outcomes in breast cancer.
  • Lin28's pleiotropic gene regulation suggests a common theme of targeting multiple pathways in cancer.